212 related articles for article (PubMed ID: 35501806)
1. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
Vogelmeier CF; Worth H; Buhl R; Criée CP; Gückel E; Kardos P
Respir Res; 2022 May; 23(1):109. PubMed ID: 35501806
[TBL] [Abstract][Full Text] [Related]
2. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
Suissa S; Dell'Aniello S; Ernst P
Chest; 2020 Apr; 157(4):846-855. PubMed ID: 31759966
[TBL] [Abstract][Full Text] [Related]
5. A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.
Miravitlles M; Verhamme K; Calverley PMA; Dreher M; Bayer V; Gardev A; de la Hoz A; Wedzicha J; Price D
Int J Chron Obstruct Pulmon Dis; 2022; 17():545-558. PubMed ID: 35309285
[TBL] [Abstract][Full Text] [Related]
6. A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT
Buhl R; Dreher M; Korn S; Taube C; Stock C; Zehendner CM; Kondla A; Vogelmeier CF
Int J Chron Obstruct Pulmon Dis; 2020; 15():2601-2608. PubMed ID: 33122898
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
8. Stepwise management of COPD: What is next after bronchodilation?
Miravitlles M; Matsunaga K; Dreher M
Ther Adv Respir Dis; 2023; 17():17534666231208630. PubMed ID: 37936381
[TBL] [Abstract][Full Text] [Related]
9. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS.
Buhl R; Dreher M; Mattiucci-Guehlke M; Emerson-Stadler R; Eckhardt S; Taube C; Vogelmeier CF
Adv Ther; 2023 Jul; 40(7):3263-3278. PubMed ID: 37256536
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
11. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.
Vanfleteren L; Fabbri LM; Papi A; Petruzzelli S; Celli B
Int J Chron Obstruct Pulmon Dis; 2018; 13():3971-3981. PubMed ID: 30587953
[TBL] [Abstract][Full Text] [Related]
12. The clinical characteristics and outcomes of different inhaled therapies in chronic obstructive pulmonary disease patients with frequent cough.
Li X; Song Q; Cheng W; Liu C; Lin L; Li J; Peng Y; Zeng Y; Yi R; Liu Y; Li X; Chen Y; Cai S; Chen P
Ann Med; 2023; 55(2):2304107. PubMed ID: 38233371
[TBL] [Abstract][Full Text] [Related]
13. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
[TBL] [Abstract][Full Text] [Related]
14. When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment.
Cheng WC; Wu BR; Liao WC; Chen CY; Chen WC; Hsia TC; Tu CY; Chen CH; Hsu WH
Int J Chron Obstruct Pulmon Dis; 2020; 15():3375-3384. PubMed ID: 33376318
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Patients with Chronic Obstructive Pulmonary Disease Treated with Long-Acting Bronchodilators in a Real-World Setting in Singapore: A Single-Center Observational Study.
Sim M; Yii A; Xu X; Bahety P; Loh CH; Navarro Rojas AA; Milea D; Tee A
Int J Chron Obstruct Pulmon Dis; 2022; 17():1349-1363. PubMed ID: 35711173
[TBL] [Abstract][Full Text] [Related]
16. Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database.
Milea D; Yeo SH; Nam Y; Navarro Rojas AA; Shantakumar S; Beale J; Marett B; Young RP; Scott RJ; Gribben B
Int J Chron Obstruct Pulmon Dis; 2021; 16():1075-1091. PubMed ID: 33907394
[TBL] [Abstract][Full Text] [Related]
17. COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners.
Meeraus W; Wood R; Jakubanis R; Holbrook T; Bizouard G; Despres J; Silva CCD; Nachbaur G; Landis SH; Punekar Y; Aguilaniu B; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2019; 14():51-63. PubMed ID: 30587961
[TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
Bloom CI; Douglas I; Usmani OS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis.
Lee HW; Kim HJ; Jang EJ; Lee CH
Respiration; 2021; 100(7):631-643. PubMed ID: 33971649
[TBL] [Abstract][Full Text] [Related]
20. Initiation of Triple Therapy with Multiple Inhalers in Chronic Obstructive Pulmonary Disease: An Analysis of Treatment Patterns from a U.S. Retrospective Database Study.
Lane DC; Stemkowski S; Stanford RH; Tao Z
J Manag Care Spec Pharm; 2018 Nov; 24(11):1165-1172. PubMed ID: 30362922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
